PAVmed SG&A Expense (Quarterly) Insights

PAVmed Inc (PAVM)

2.10 -0.14 (-6.25%) USD | NASDAQ | May 03, 16:00

2.10 0.00 (0.00%) After-Hours: 16:19

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	11.72M
September 30, 2023	10.87M
June 30, 2023	10.99M
March 31, 2023	14.56M
December 31, 2022	15.92M
September 30, 2022	15.11M
June 30, 2022	16.09M
March 31, 2022	13.40M
December 31, 2021	12.45M
September 30, 2021	8.402M
June 30, 2021	8.712M
March 31, 2021	4.762M
December 31, 2020	5.446M
September 30, 2020	2.222M
June 30, 2020	2.421M
March 31, 2020	2.625M
December 31, 2019	2.334M
September 30, 2019	1.724M

Date	Value
June 30, 2019	1.914M
March 31, 2019	1.693M
December 31, 2018	1.944M
September 30, 2018	1.396M
June 30, 2018	1.59M
March 31, 2018	1.380M
December 31, 2017	1.330M
September 30, 2017	1.263M
June 30, 2017	1.320M
March 31, 2017	1.500M
December 31, 2016	1.104M
September 30, 2016	1.350M
June 30, 2016	0.9597M
March 31, 2016	0.5177M
December 31, 2015	0.5894M
September 30, 2015	0.2744M
June 30, 2015	0.2932M
March 31, 2015	0.1303M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.724M

Minimum

Sep 2019

16.09M

Maximum

Jun 2022

8.509M

Average

8.712M

Median

Jun 2021

SG&A Expense (Quarterly) Benchmarks